| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
50,131,000 |
| Market
Cap: |
10.46(B) |
| Last
Volume: |
489,548 |
Avg
Vol: |
300,206 |
| 52
Week Range: |
$179.39 - $274.11 |
|
| Level
I Sector: |
Conglomerates |
| Level
II Sector: |
Conglomerates |
| Level
III Sector: |
Conglomerates |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 999 |
| Guru Rank Value : 0 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Teleflex is a provider of medical technology products. Co. primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. Co.'s product categories within its geographic segments include vascular access, which provides devices that facilitate a variety of critical care therapies and other applications; anesthesia, which comprised of airway and pain management product lines; and interventional, which consist of a variety of coronary catheters, structural heart therapies, and peripheral intervention products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
7,401 |
47,609 |
50,630 |
66,973 |
| Total Sell Value |
$1,665,225 |
$11,344,919 |
$12,087,209 |
$16,173,452 |
| Total People Sold |
1 |
3 |
4 |
4 |
| Total Sell Transactions |
1 |
3 |
4 |
5 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Deren John |
VP & Chief Accounting Officer |
• – – |
2020-02-28 |
4 |
D |
$335.02 |
$51,593 |
D/D |
(154) |
2,079 |
|
- |
|
| Powell Thomas E |
Executive Vice President & CFO |
• – – |
2020-02-28 |
4 |
D |
$335.02 |
$346,746 |
D/D |
(1,035) |
10,993 |
|
- |
|
| Kelly Liam |
President & CEO |
• • – |
2020-02-28 |
4 |
D |
$335.02 |
$345,406 |
D/D |
(1,031) |
23,355 |
|
- |
|
| Leyden James L |
VP, General Counsel, Secretary |
• – – |
2020-02-27 |
4 |
S |
$344.26 |
$258,207 |
D/D |
(750) |
15,886 |
|
-7% |
|
| Leyden James L |
VP, General Counsel, Secretary |
• – – |
2020-02-27 |
4 |
D |
$344.44 |
$242,830 |
D/D |
(705) |
16,636 |
|
- |
|
| Leyden James L |
VP, General Counsel, Secretary |
• – – |
2020-02-27 |
4 |
OE |
$61.34 |
$196,288 |
D/D |
3,200 |
17,341 |
|
- |
|
| Deren John |
VP & Chief Accounting Officer |
• – – |
2020-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
222 |
2,233 |
|
- |
|
| Klasko Stephen K. M.d. |
Director |
– • – |
2020-02-25 |
4 |
AS |
$360.95 |
$72,190 |
D/D |
(200) |
738 |
|
2% |
|
| Klasko Stephen K. M.d. |
Director |
– • – |
2020-02-25 |
4 |
OE |
$58.25 |
$11,650 |
D/D |
200 |
938 |
|
- |
|
| Winters James |
Vice President, Mfg and Supply |
• – – |
2020-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
331 |
963 |
|
- |
|
| Wijker Mario |
Vice President, QARA |
• – – |
2020-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
199 |
582 |
|
- |
|
| Kelly Liam |
President & CEO |
• • – |
2020-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,215 |
24,386 |
|
- |
|
| Hicks Cameron P |
Vice President, Global HR |
• – – |
2020-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
410 |
7,516 |
|
- |
|
| Powell Thomas E |
Executive Vice President & CFO |
• – – |
2020-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,331 |
12,028 |
|
- |
|
| Leyden James L |
VP, General Counsel, Secretary |
• – – |
2020-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
614 |
14,141 |
|
- |
|
| Smith Benson |
Director |
– • – |
2020-02-18 |
4 |
D |
$376.44 |
$416,343 |
D/D |
(1,106) |
47,861 |
|
- |
|
| Klasko Stephen K. M.d. |
Director |
– • – |
2020-01-27 |
4 |
AS |
$375.71 |
$75,142 |
D/D |
(200) |
736 |
|
-2% |
|
| Klasko Stephen K. M.d. |
Director |
– • – |
2020-01-27 |
4 |
OE |
$58.25 |
$11,650 |
D/D |
200 |
936 |
|
- |
|
| Klasko Stephen K. M.d. |
Director |
– • – |
2019-12-26 |
4 |
AS |
$374.35 |
$74,870 |
D/D |
(200) |
736 |
|
- |
|
| Klasko Stephen K. M.d. |
Director |
– • – |
2019-12-26 |
4 |
OE |
$61.34 |
$12,268 |
D/D |
200 |
936 |
|
- |
|
| Hicks Cameron P |
Vice President, Global HR |
• – – |
2019-11-29 |
4 |
OE |
$85.54 |
$85,540 |
D/D |
1,000 |
7,106 |
|
- |
|
| Hicks Cameron P |
Vice President, Global HR |
• – – |
2019-11-26 |
4 |
S |
$350.00 |
$455,000 |
D/D |
(1,300) |
6,106 |
|
- |
|
| Hicks Cameron P |
Vice President, Global HR |
• – – |
2019-11-26 |
4 |
OE |
$85.54 |
$111,202 |
D/D |
1,300 |
7,406 |
|
- |
|
| Powell Thomas E |
Executive Vice President & CFO |
• – – |
2019-11-26 |
4 |
AS |
$347.31 |
$1,743,510 |
D/D |
(5,000) |
10,697 |
|
- |
|
| Powell Thomas E |
Executive Vice President & CFO |
• – – |
2019-11-26 |
4 |
OE |
$121.00 |
$605,000 |
D/D |
5,000 |
15,697 |
|
- |
|
1100 Records found
|
|
Page 8 of 44 |
|
|
0.27 (0.13%) 
